» Articles » PMID: 2308957

Pahhph-5: a Mouse Mutant Deficient in Phenylalanine Hydroxylase

Overview
Specialty Science
Date 1990 Mar 1
PMID 2308957
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Mutant mice exhibiting heritable hyperphenylalaninemia have been isolated after ethylnitrosourea mutagenesis of the germ line. We describe one mutant pedigree in which phenylalanine hydroxylase activity is severely deficient in homozygotes and reduced in heterozygotes while other biochemical components of phenylalanine catabolism are normal. In homozygotes, injection of phenylalanine causes severe hyperphenylalaninemia and urinary excretion of phenylketones but not hypertyrosinemia. Severe chronic hyperphenylalaninemia can be produced when mutant homozygotes are given phenylalanine in their drinking water. Genetic mapping has localized the mutation to murine chromosome 10 at or near the Pah locus, the structural gene for phenylalanine hydroxylase. This mutant provides a useful genetic animal model affected in the same enzyme as in human phenylketonuria.

Citing Articles

Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria.

Baek R, Coughlan K, Jiang L, Liang M, Ci L, Singh H Nat Commun. 2024; 15(1):3804.

PMID: 38714648 PMC: 11076592. DOI: 10.1038/s41467-024-47460-9.


State-of-the-art 2023 on gene therapy for phenylketonuria.

Martinez M, Harding C, Schwank G, Thony B J Inherit Metab Dis. 2023; 47(1):80-92.

PMID: 37401651 PMC: 10764640. DOI: 10.1002/jimd.12651.


Genetic etiology and clinical challenges of phenylketonuria.

Elhawary N, AlJahdali I, Abumansour I, Elhawary E, Gaboon N, Dandini M Hum Genomics. 2022; 16(1):22.

PMID: 35854334 PMC: 9295449. DOI: 10.1186/s40246-022-00398-9.


Modeling the cognitive effects of diet discontinuation in adults with phenylketonuria (PKU) using pegvaliase therapy in PAH-deficient mice.

Winn S, Dudley S, Scherer T, Rimann N, Thony B, Boutros S Mol Genet Metab. 2022; 136(1):46-64.

PMID: 35339387 PMC: 9106909. DOI: 10.1016/j.ymgme.2022.03.008.


A universal strategy for AAV delivery of base editors to correct genetic point mutations in neonatal PKU mice.

Zhou L, Su J, Long J, Tao R, Tang W, Qin F Mol Ther Methods Clin Dev. 2022; 24:230-240.

PMID: 35141352 PMC: 8803597. DOI: 10.1016/j.omtm.2022.01.001.


References
1.
Kaufman S . Phenylalanine hydroxylase from rat liver. Methods Enzymol. 1978; 53:278-86. DOI: 10.1016/s0076-6879(78)53034-6. View

2.
Zannoni V . Liver phenylalanine hydroxylase assay. Biochem Med. 1976; 16(3):251-3. DOI: 10.1016/0006-2944(76)90030-2. View

3.
RUSSELL W, Kelly E, Hunsicker P, BANGHAM J, Maddux S, Phipps E . Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci U S A. 1979; 76(11):5818-9. PMC: 411742. DOI: 10.1073/pnas.76.11.5818. View

4.
Parniak M, Kaufman S . Rat liver phenylalanine hydroxylase. Activation by sulfhydryl modification. J Biol Chem. 1981; 256(13):6876-82. View

5.
Arai N, Narisawa K, Hayakawa H, Tada K . Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots. Pediatrics. 1982; 70(3):426-30. View